Featured Posts

Support for fast-tracking new drugs into clinical trials for childhood acute leukemia

Children's Cancer Institute, under the direction of Principal Investigator, Professor Richard Lock, Head of the Leukaemia Biology Program, has been awarded close to US$2 million for 5 years under the Pediatric Preclinical Testing Consortium (PPTC), created by NCI to prioritise and fast-track new drugs into clinical trials in children with aggressive cancers.

Read more here: http://www.eurekalert.org/pub_releases/2015-09/ccia-sff090815.php

Posts Are Coming Soon
Stay tuned...
Recent Posts
Archive
Search By Tags
Follow Us
  • Facebook Basic Square
  • Twitter Basic Square

524 Bayfield Street North
P.O. Box 20005
Barrie, ON L4M 5E9
Canada

info@opacc.org

1-888-290-5496

  • Wix Facebook page
  • Wix Twitter page
  • Instagram Social Icon
  • LinkedIn Social Icon
  • YouTube Social  Icon